Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Marks

Showing results (491-500 of 683) with videos related to

Pageof 69
Sort By:
Bone Marrow Transplantation|July 1, 1996
Hepatic dysfunction following busulfan and cyclophosphamide myeloablation: a retrospective, multicenter analysisM J Styler, P Crilley, J Biggs, et al.
Plos One|March 12, 2015
Variation in responses of fishes across multiple reserves within a network of marine protected areas in temperate watersRichard M Starr, Dean E Wendt, Cheryl L Barnes, et al.
The Journal of Pediatrics|July 1, 1986
Cefuroxime versus ampicillin plus chloramphenicol in childhood bacterial meningitis: a multicenter randomized controlled trialW A Marks, H R Stutman, M I Marks, et al.
Blood|September 25, 1999
Children with acute lymphoblastic leukemia who receive T-cell-depleted HLA mismatched marrow allografts from unrelated donors have an increased incidence of primary graft failure but a similar overall transplant outcomeA Green, E Clarke, L Hunt, et al.
Leukemia & Lymphoma|May 8, 2020
Impact of salvage treatment phase on inotuzumab ozogamicin treatment for relapsed/refractory acute lymphoblastic leukemia: an update from the INO-VATE final study databaseElias Jabbour, Matthias Stelljes, Anjali S Advani, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 27, 2017
Reduced cellularity of bone marrow in multiple sclerosis with decreased MSC expansion potential and premature ageing in vitroJuliana Redondo, Pamela Sarkar, Kevin Kemp, et al.
Leukemia|August 3, 2016
Pegylated-asparaginase during induction therapy for adult acute lymphoblastic leukaemia: toxicity data from the UKALL14 trialB Patel, A A Kirkwood, A Dey, et al.
Bone Marrow Transplantation|February 16, 2010
The role of allogeneic SCT in primary myelofibrosis: a British Society for Blood and Marrow Transplantation studyW A Stewart, R Pearce, K E Kirkland, et al.
British Journal of Haematology|August 18, 2020
Impact of number of cycles on outcomes of patients with relapsed or refractory acute lymphoblastic leukaemia treated with inotuzumab ozogamicinRyan D Cassaday, David I Marks, Daniel J DeAngelo, et al.
British Journal of Haematology|March 15, 2024
Practice guideline: Preparation for CAR T-cell therapy in children and young adults with B-acute lymphoblastic leukaemiaAvijeet Kumar Mishra, Saskia Burridge, Macarena Oporto Espuelas, et al.
Pageof 69

Showing results (491-500 of 683) with videos related to

Sort By:
Pageof 69
Bone Marrow Transplantation|July 1, 1996
Hepatic dysfunction following busulfan and cyclophosphamide myeloablation: a retrospective, multicenter analysisM J Styler, P Crilley, J Biggs, et al.
Plos One|March 12, 2015
Variation in responses of fishes across multiple reserves within a network of marine protected areas in temperate watersRichard M Starr, Dean E Wendt, Cheryl L Barnes, et al.
The Journal of Pediatrics|July 1, 1986
Cefuroxime versus ampicillin plus chloramphenicol in childhood bacterial meningitis: a multicenter randomized controlled trialW A Marks, H R Stutman, M I Marks, et al.
Blood|September 25, 1999
Children with acute lymphoblastic leukemia who receive T-cell-depleted HLA mismatched marrow allografts from unrelated donors have an increased incidence of primary graft failure but a similar overall transplant outcomeA Green, E Clarke, L Hunt, et al.
Leukemia & Lymphoma|May 8, 2020
Impact of salvage treatment phase on inotuzumab ozogamicin treatment for relapsed/refractory acute lymphoblastic leukemia: an update from the INO-VATE final study databaseElias Jabbour, Matthias Stelljes, Anjali S Advani, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 27, 2017
Reduced cellularity of bone marrow in multiple sclerosis with decreased MSC expansion potential and premature ageing in vitroJuliana Redondo, Pamela Sarkar, Kevin Kemp, et al.
Leukemia|August 3, 2016
Pegylated-asparaginase during induction therapy for adult acute lymphoblastic leukaemia: toxicity data from the UKALL14 trialB Patel, A A Kirkwood, A Dey, et al.
Bone Marrow Transplantation|February 16, 2010
The role of allogeneic SCT in primary myelofibrosis: a British Society for Blood and Marrow Transplantation studyW A Stewart, R Pearce, K E Kirkland, et al.
British Journal of Haematology|August 18, 2020
Impact of number of cycles on outcomes of patients with relapsed or refractory acute lymphoblastic leukaemia treated with inotuzumab ozogamicinRyan D Cassaday, David I Marks, Daniel J DeAngelo, et al.
British Journal of Haematology|March 15, 2024
Practice guideline: Preparation for CAR T-cell therapy in children and young adults with B-acute lymphoblastic leukaemiaAvijeet Kumar Mishra, Saskia Burridge, Macarena Oporto Espuelas, et al.
Pageof 69